Compare Insurance Relaunches Travel Insurance
Compare Insurance would like to announce that it’s once again offering Travel Insurance to customers…
6 years ago
Cyberton Partners with CyCognito – Leader in Shadow Risk Elimination
This relationship will see Cyberton taking CyCognito to the Middle East and North Africa market.…
6 years ago
Cyberton Brings Advanced Threat Detection to MENA by Partnering with Acalvio Technologies
This relationship will see Cyberton taking Acalvio to the MENA market. Dubai, United Arab Emirates,…
6 years ago
India Appliances Space – Time to Finally Embrace Digitization Post COVID-19? – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "India Appliances Space - Time to Finally Embrace Digitization Post COVID?" report has…
6 years ago
AM Best Revises Issuer Credit Rating Outlook to Positive for China Reinsurance (Group) Corporation and Its Subsidiaries; Affirms Credit Ratings of China Reinsurance (Hong Kong) Company Limited
HONG KONG--(BUSINESS WIRE)--AM Best has revised the outlook to positive from stable for the Long-Term…
6 years ago
Esker and Birlasoft Partner to Automate Procure-to-Pay and Order-to-Cash with Artificial Intelligence
Birlasoft brings Esker’s cloud technology suite to global customers LYON, France, MIDDLETON, Wis., DELHI, India…
6 years ago
Tablo Hemodialysis Systems Deployed to Guam Hospitals by U.S. Department of Health and Human Services for Emergency Response
Guam to receive HHS emergency deployment of Outset Medical’s mobile, easy-to-use dialysis technology for patients…
6 years ago
Internet Society Foundation Awards Over $1 Million in Digital Skills Development Grants
Grants will support community-focused organizations in Bangladesh, Colombia, and Senegal RESTON, Va.--(BUSINESS WIRE)--The Internet Society…
6 years ago
E Ink Wins Taiwan Corporate Sustainability Awards for Fourth Consecutive Year
Awards recognize Company’s ESG performance BILLERICA, Mass.--(BUSINESS WIRE)--E Ink Holdings, “E Ink” (8069.TW), the leading…
6 years ago
Alvotech Announces That the U.S. FDA and EMA Have Accepted Regulatory Submissions for AVT02, a Proposed Biosimilar to HUMIRA® (adalimumab)
Alvotech is developing AVT02 as a proposed biosimilar to HUMIRA® (adalimumab) with high concentration (100mg/mL)…
6 years ago